Meningitis in critically ill patients admitted to intensive care unit for severe community-acquired pneumococcal pneumonia.
Lumbar puncture
Mortality
Neurological sequelae
Prognosis
Streptococcus pneumoniae
Journal
Annals of intensive care
ISSN: 2110-5820
Titre abrégé: Ann Intensive Care
Pays: Germany
ID NLM: 101562873
Informations de publication
Date de publication:
18 Dec 2023
18 Dec 2023
Historique:
received:
12
07
2023
accepted:
06
11
2023
medline:
18
12
2023
pubmed:
18
12
2023
entrez:
18
12
2023
Statut:
epublish
Résumé
Although it has been reported that patients with pneumococcal pneumonia may develop meningitis, lumbar puncture is not systematically recommended in these patients, even in patients with associated bacteremia or invasive pneumococcal disease. The aim of this study was to determine the characteristics and outcomes of patients admitted to intensive care unit (ICU) for pneumococcal community-acquired pneumonia who developed meningitis. We retrospectively included all consecutive patients admitted to our ICU from January 2006 to December 2020 for severe pneumococcal community-acquired pneumonia according to American Thoracic Society criteria. Meningitis was defined as pleocytosis > 5 cells/mm Overall, 262 patients [64(52-75) years old] were included: 154(59%) were male, 80(30%) had chronic respiratory disease, 105(39%) were immunocompromised and 6(2%) were vaccinated against S. pneumoniae. A lumbar puncture was performed in 88(34%) patients with a delay from ICU admission to puncture lumbar of 10.5 (2.8-24.1) h and after the initiation of pneumococcal antibiotherapy in 81(92%) patients. Meningitis was diagnosed in 14 patients: 16% of patients with lumbar puncture and 5% of patients in the whole population. Patients with meningitis had more frequently human immunodeficiency virus positive status (29 vs. 5%, p = 0.02), neurological deficits on ICU admission (43 vs. 16%, p = 0.03) and pneumococcal bacteremia (71 vs. 30%, p < 0.01) than those without. The ICU mortality rate (14 vs. 13%, p = 0.73) and the mortality rate at Day-90 (21 vs. 15%, p = 0.83) did not differ between patients with and without meningitis. The proportion of patients with neurological disorders at ICU discharge was higher in patients with meningitis (64 vs. 23%, p < 0.001) than in those without. The other outcomes did not differ at ICU discharge, Day-30 and Day-90 between the two groups of patients. Meningitis was diagnosed in 16% of patients with severe pneumococcal community-acquired pneumonia in whom a lumbar puncture was performed, was more frequent in patients with pneumococcal bacteremia and was associated with more frequent neurological disorders at ICU discharge. Further studies are needed to confirm these results.
Sections du résumé
BACKGROUND
BACKGROUND
Although it has been reported that patients with pneumococcal pneumonia may develop meningitis, lumbar puncture is not systematically recommended in these patients, even in patients with associated bacteremia or invasive pneumococcal disease. The aim of this study was to determine the characteristics and outcomes of patients admitted to intensive care unit (ICU) for pneumococcal community-acquired pneumonia who developed meningitis.
METHODS
METHODS
We retrospectively included all consecutive patients admitted to our ICU from January 2006 to December 2020 for severe pneumococcal community-acquired pneumonia according to American Thoracic Society criteria. Meningitis was defined as pleocytosis > 5 cells/mm
RESULTS
RESULTS
Overall, 262 patients [64(52-75) years old] were included: 154(59%) were male, 80(30%) had chronic respiratory disease, 105(39%) were immunocompromised and 6(2%) were vaccinated against S. pneumoniae. A lumbar puncture was performed in 88(34%) patients with a delay from ICU admission to puncture lumbar of 10.5 (2.8-24.1) h and after the initiation of pneumococcal antibiotherapy in 81(92%) patients. Meningitis was diagnosed in 14 patients: 16% of patients with lumbar puncture and 5% of patients in the whole population. Patients with meningitis had more frequently human immunodeficiency virus positive status (29 vs. 5%, p = 0.02), neurological deficits on ICU admission (43 vs. 16%, p = 0.03) and pneumococcal bacteremia (71 vs. 30%, p < 0.01) than those without. The ICU mortality rate (14 vs. 13%, p = 0.73) and the mortality rate at Day-90 (21 vs. 15%, p = 0.83) did not differ between patients with and without meningitis. The proportion of patients with neurological disorders at ICU discharge was higher in patients with meningitis (64 vs. 23%, p < 0.001) than in those without. The other outcomes did not differ at ICU discharge, Day-30 and Day-90 between the two groups of patients.
CONCLUSION
CONCLUSIONS
Meningitis was diagnosed in 16% of patients with severe pneumococcal community-acquired pneumonia in whom a lumbar puncture was performed, was more frequent in patients with pneumococcal bacteremia and was associated with more frequent neurological disorders at ICU discharge. Further studies are needed to confirm these results.
Identifiants
pubmed: 38108904
doi: 10.1186/s13613-023-01211-z
pii: 10.1186/s13613-023-01211-z
doi:
Types de publication
Journal Article
Langues
eng
Pagination
129Informations de copyright
© 2023. The Author(s).
Références
Garnacho-Montero J, Barrero-Garcia I, Gomez-Prieto MG, Martin-Loeches I. Severe community-acquired pneumonia: current management and future therapeutic alternatives. Expert Rev Anti Infect Ther. 2018;16(9):667–77.
doi: 10.1080/14787210.2018.1512403
pubmed: 30118377
Kochanek KD, Murphy SL, Xu J, Arias E. Deaths: final data for 2017. Natl Vital Stat Rep. 2019;68(9):1–77.
pubmed: 32501199
Troeger C, Blacker B, Khalil IA, Rao PC, Cao J, Zimsen S, et al. Estimates of the global, regional, and national morbidity, mortality, and aetiologies of lower respiratory infections in 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Infect Dis. 2018;18(11):1191–210.
doi: 10.1016/S1473-3099(18)30310-4
File TM Jr. Streptococcus pneumoniae and community-acquired pneumonia: a cause for concern. Am J Med. 2004;117:39S-50S.
pubmed: 15360096
Jain S, Self WH, Wunderink RG, Fakhran S, Balk R, Bramley AM, et al. Community-acquired pneumonia requiring hospitalization among U.S. adults. N EngL J Med. 2015;373(5):415–27.
doi: 10.1056/NEJMoa1500245
pubmed: 26172429
pmcid: 4728150
Weiser JN, Ferreira DM, Paton JC. Streptococcus pneumoniae: transmission, colonization and invasion. Nat Rev Microbiol. 2018;16(6):355–67.
doi: 10.1038/s41579-018-0001-8
pubmed: 29599457
pmcid: 5949087
Bedos JP, Varon E, Porcher R, Asfar P, Le Tulzo Y, Megarbane B, et al. Host-pathogen interactions and prognosis of critically ill immunocompetent patients with pneumococcal pneumonia: the nationwide prospective observational STREPTOGENE study. Intensive Care Med. 2018;44(12):2162–73.
doi: 10.1007/s00134-018-5444-x
pubmed: 30456466
Dupuis C, Sabra A, Patrier J, Chaize G, Saighi A, Feger C, et al. Burden of pneumococcal pneumonia requiring ICU admission in France: 1-year prognosis, resources use, and costs. Crit Care. 2021;25(1):24.
doi: 10.1186/s13054-020-03442-z
pubmed: 33423691
pmcid: 7798246
Mongardon N, Max A, Bougle A, Pene F, Lemiale V, Charpentier J, et al. Epidemiology and outcome of severe pneumococcal pneumonia admitted to intensive care unit: a multicenter study. Crit Care. 2012;16(4):R155.
doi: 10.1186/cc11471
pubmed: 22894879
pmcid: 3580745
Anil A, Banerjee A. Pneumococcal encounter with the blood-brain barrier endothelium. Front Cell Infect Microbiol. 2020;10:590682.
doi: 10.3389/fcimb.2020.590682
pubmed: 33224900
pmcid: 7669544
Georges H, Leroy O, Vandenbussche C, Guery B, Alfandari S, Tronchon L, et al. Epidemiological features and prognosis of severe community-acquired pneumococcal pneumonia. Intensive Care Med. 1999;25(2):198–206.
doi: 10.1007/s001340050816
pubmed: 10193548
Moine P, Vercken JB, Chevret S, Gajdos P. Severe community-acquired pneumococcal pneumonia. The French Study Group of Community-Acquired Pneumonia in ICU. Scand J Infect Dis. 1995;27(3):201–6.
doi: 10.3109/00365549509019009
pubmed: 8539541
Mazeraud A, Righy C, Bouchereau E, Benghanem S, Bozza FA, Sharshar T. Septic-associated encephalopathy: a comprehensive review. Neurotherapeutics. 2020;17(2):392–403.
doi: 10.1007/s13311-020-00862-1
pubmed: 32378026
pmcid: 7283452
Mandell LA, Bartlett JG, Dowell SF, File TM Jr, Musher DM, Whitney C, et al. Update of practice guidelines for the management of community-acquired pneumonia in immunocompetent adults. Clin Infect Dis. 2003;37(11):1405–33.
doi: 10.1086/380488
pubmed: 14614663
Sonneville R, de Montmollin E, Contou D, Ferrer R, Gurjar M, Klouche K, et al. Clinical features, etiologies, and outcomes in adult patients with meningoencephalitis requiring intensive care (EURECA): an international prospective multicenter cohort study. Intensive Care Med. 2023;49(5):517–29.
doi: 10.1007/s00134-023-07032-9
pubmed: 37022378
von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP, et al. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet. 2007;370(9596):1453–7.
doi: 10.1016/S0140-6736(07)61602-X
Metlay JP, Waterer GW, Long AC, Anzueto A, Brozek J, Crothers K, et al. Diagnosis and treatment of adults with community-acquired pneumonia. An official clinical practice guideline of the american thoracic society and infectious diseases society of america. Am J Respir Crit Care Med. 2019;200(7):e45–67.
doi: 10.1164/rccm.201908-1581ST
pubmed: 31573350
pmcid: 6812437
Jennett B, Bond M. Assessment of outcome after severe brain damage. Lancet. 1975;1(7905):480–4.
doi: 10.1016/S0140-6736(75)92830-5
pubmed: 46957
McGill F, Heyderman RS, Panagiotou S, Tunkel AR, Solomon T. Acute bacterial meningitis in adults. Lancet. 2016;388(10063):3036–47.
doi: 10.1016/S0140-6736(16)30654-7
pubmed: 27265346
van de Beek D, Cabellos C, Dzupova O, Esposito S, Klein M, Kloek AT, et al. ESCMID guideline: diagnosis and treatment of acute bacterial meningitis. Clin Microbiol Infect. 2016;22(Suppl 3):S37-62.
doi: 10.1016/j.cmi.2016.01.007
pubmed: 27062097
Seehusen DA, Reeves MM, Fomin DA. Cerebrospinal fluid analysis. Am Fam Physician. 2003;68(6):1103–8.
pubmed: 14524396
Bellut H, Porcher R, Varon E, Asfar P, Le Tulzo Y, Megarbane B, et al. Comparison of prognostic factors between bacteraemic and non-bacteraemic critically ill immunocompetent patients in community-acquired severe pneumococcal pneumonia: a STREPTOGENE sub-study. Ann Intensive Care. 2021;11(1):148.
doi: 10.1186/s13613-021-00936-z
pubmed: 34689255
pmcid: 8542522
Figueiredo AHA, Brouwer MC, Bijlsma MW, van der Ende A, van de Beek D. Community-acquired pneumonia in patients with bacterial meningitis: a prospective nationwide cohort study. Clin Microbiol Infect. 2020;26(4):513.
doi: 10.1016/j.cmi.2019.09.001
Spanos A, Harrell FE Jr, Durack DT. Differential diagnosis of acute meningitis. An analysis of the predictive value of initial observations. JAMA. 1989;262(19):2700–7.
doi: 10.1001/jama.1989.03430190084036
pubmed: 2810603
Holler JG, Brandt CT, Leib SL, Rowland IJ, Ostergaard C. Increase in hippocampal water diffusion and volume during experimental pneumococcal meningitis is aggravated by bacteremia. BMC Infect Dis. 2014;14:240.
doi: 10.1186/1471-2334-14-240
pubmed: 24886045
pmcid: 4016615
Mook-Kanamori BB, Geldhoff M, van der Poll T, van de Beek D. Pathogenesis and pathophysiology of pneumococcal meningitis. Clin Microbiol Rev. 2011;24(3):557–91.
doi: 10.1128/CMR.00008-11
pubmed: 21734248
pmcid: 3131058
Mora Carpio AL, Stempel JM. Pneumococcal Bacteremia and Meningitis. N Engl J Med. 2018;379(21):2063.
doi: 10.1056/NEJMicm1806754
pubmed: 30462944
Mehta AJ. Alcoholism and critical illness: A review. World J Crit Care Med. 2016;5(1):27–35.
doi: 10.5492/wjccm.v5.i1.27
pubmed: 26855891
pmcid: 4733453
Koelman DLH, Brouwer MC, Ter Horst L, Bijlsma MW, van der Ende A, van de Beek D. Pneumococcal meningitis in adults: a prospective nationwide cohort study over a 20-year period. Clin Infect Dis. 2022;74(4):657–67.
doi: 10.1093/cid/ciab477
pubmed: 34036322
Mourvillier B, Tubach F, van de Beek D, Garot D, Pichon N, Georges H, et al. Induced hypothermia in severe bacterial meningitis: a randomized clinical trial. JAMA. 2013;310(20):2174–83.
doi: 10.1001/jama.2013.280506
pubmed: 24105303
Weisfelt M, de Gans J, van der Poll T, van de Beek D. Pneumococcal meningitis in adults: new approaches to management and prevention. Lancet Neurol. 2006;5(4):332–42.
doi: 10.1016/S1474-4422(06)70409-4
pubmed: 16545750
Weisfelt M, van de Beek D, Spanjaard L, Reitsma JB, de Gans J. Clinical features, complications, and outcome in adults with pneumococcal meningitis: a prospective case series. Lancet Neurol. 2006;5(2):123–9.
doi: 10.1016/S1474-4422(05)70288-X
pubmed: 16426988
van de Beek D, de Gans J, Spanjaard L, Weisfelt M, Reitsma JB, Vermeulen M. Clinical features and prognostic factors in adults with bacterial meningitis. N Engl J Med. 2004;351(18):1849–59.
doi: 10.1056/NEJMoa040845
pubmed: 15509818
Kastenbauer S, Pfister HW. Pneumococcal meningitis in adults: spectrum of complications and prognostic factors in a series of 87 cases. Brain. 2003;126(Pt 5):1015–25.
doi: 10.1093/brain/awg113
pubmed: 12690042
Tubiana S, Varon E, Biron C, Ploy MC, Mourvillier B, Taha MK, et al. Community-acquired bacterial meningitis in adults: in-hospital prognosis, long-term disability and determinants of outcome in a multicentre prospective cohort. Clin Microbiol Infect. 2020;26(9):1192–200.
doi: 10.1016/j.cmi.2019.12.020
pubmed: 31927117
Voiriot G, Oualha M, Pierre A, Salmon-Gandonniere C, Gaudet A, Jouan Y, et al. Chronic critical illness and post-intensive care syndrome: from pathophysiology to clinical challenges. Ann Intensive Care. 2022;12(1):58.
doi: 10.1186/s13613-022-01038-0
pubmed: 35779142
pmcid: 9250584